24/7 Market News- Prime Medicine Enters Strategic Research Collaboration and License Agreement with Bristol Myers Squibb and Reveals Strategically Focused Pipeline
DENVER, Colo., Sep 30, 2024 (247marketnews.com)- Prime Medicine, Inc. (Nasdaq: PRME) reported entering a strategic research collaboration and license agreement...